ロード中...
Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?
Many recent studies have demonstrated the range of disorders in which monoclonal antibodies have a clinical role. The monoclonal antibody NA1/34, directed against a surface antigen present on lesional cells ('LCH cells'), has been found to localise in vivo to sites of disease. This review...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1994
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2149709/ https://ncbi.nlm.nih.gov/pubmed/8075008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|